Charles River announces new $300 million accelerated stock repurchase program
Charles River Laboratories International, Inc. announced today that it has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost …
Read more on News-Medical-Net
28 Aug
